These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 23212765)

  • 1. Does histologic type correlate to outcome after pelvic exenteration for cervical and vaginal cancer?
    Baiocchi G; Guimaraes GC; Faloppa CC; Kumagai LY; Oliveira RA; Begnami MD; Soares FA; Lopes A
    Ann Surg Oncol; 2013 May; 20(5):1694-700. PubMed ID: 23212765
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic factors in pelvic exenteration for gynecological malignancies.
    Baiocchi G; Guimaraes GC; Rosa Oliveira RA; Kumagai LY; Faloppa CC; Aguiar S; Begnami MD; Soares FA; Lopes A
    Eur J Surg Oncol; 2012 Oct; 38(10):948-54. PubMed ID: 22818842
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pelvic exenteration for recurrent squamous cell carcinoma of the pelvic organs arising from the cloaca--a single institution's experience over 16 years.
    Tan KK; Pal S; Lee PJ; Rodwell L; Solomon MJ
    Colorectal Dis; 2013; 15(10):1227-31. PubMed ID: 23714581
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical behaviors and outcomes for adenocarcinoma or adenosquamous carcinoma of cervix treated by radical hysterectomy and adjuvant radiotherapy or chemoradiotherapy.
    Huang YT; Wang CC; Tsai CS; Lai CH; Chang TC; Chou HH; Lee SP; Hong JH
    Int J Radiat Oncol Biol Phys; 2012 Oct; 84(2):420-7. PubMed ID: 22365621
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Clinical analysis of the recurrence of early stage bulky cervical carcinoma].
    Hu JL; Wu LY; Li XG; Zhang R; Li N; Yao HW
    Zhonghua Zhong Liu Za Zhi; 2012 May; 34(5):378-81. PubMed ID: 22883461
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of histological subtype on survival of patients with surgically-treated stage IA2-IIB cervical cancer: adenocarcinoma versus squamous cell carcinoma.
    Mabuchi S; Okazawa M; Matsuo K; Kawano M; Suzuki O; Miyatake T; Enomoto T; Kamiura S; Ogawa K; Kimura T
    Gynecol Oncol; 2012 Oct; 127(1):114-20. PubMed ID: 22728518
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pelvic exenteration for adenocarcinoma of the uterine cervix.
    Crozier M; Morris M; Levenback C; Lucas KR; Atkinson EN; Wharton JT
    Gynecol Oncol; 1995 Jul; 58(1):74-8. PubMed ID: 7789894
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Changes in the demographics and perioperative care of stage IA(2)/IB(1) cervical cancer over the past 16 years.
    Covens A; Rosen B; Murphy J; Laframboise S; DePetrillo AD; Lickrish G; Colgan T; Chapman W; Shaw P
    Gynecol Oncol; 2001 May; 81(2):133-7. PubMed ID: 11330939
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic factors for curative pelvic exenterations in patients with recurrent uterine cervical or vaginal cancer.
    Sardain H; Lavoué V; Laviolle B; Henno S; Foucher F; Levêque J
    Int J Gynecol Cancer; 2014 Nov; 24(9):1679-85. PubMed ID: 25254565
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An analysis of cell type in patients with surgically staged stage IB carcinoma of the cervix: a Gynecologic Oncology Group study.
    Look KY; Brunetto VL; Clarke-Pearson DL; Averette HE; Major FJ; Alvarez RD; Homesley HD; Zaino RJ
    Gynecol Oncol; 1996 Dec; 63(3):304-11. PubMed ID: 8946863
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic factors in stage IA-IIA cervical cancer patients treated surgically: does the waiting time to the operation affect survival?
    Umezu T; Shibata K; Kajiyama H; Yamamoto E; Mizuno M; Kikkawa F
    Arch Gynecol Obstet; 2012 Feb; 285(2):493-7. PubMed ID: 21735188
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Indications for primary and secondary exenterations in patients with cervical cancer.
    Marnitz S; Köhler C; Müller M; Behrens K; Hasenbein K; Schneider A
    Gynecol Oncol; 2006 Dec; 103(3):1023-30. PubMed ID: 16890276
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Twelve years experience with radical hysterectomy and pelvic lymphadenectomy in early stage cervical cancer.
    Suprasert P; Srisomboon J; Charoenkwan K; Siriaree S; Cheewakriangkrai C; Kietpeerakool C; Phongnarisorn C; Sae-Teng J
    J Obstet Gynaecol; 2010 Apr; 30(3):294-8. PubMed ID: 20373935
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic factors in surgically treated stage ib-iib cervical carcinomas with special emphasis on the importance of tumor volume.
    Trattner M; Graf AH; Lax S; Forstner R; Dandachi N; Haas J; Pickel H; Reich O; Staudach A; Winter R
    Gynecol Oncol; 2001 Jul; 82(1):11-6. PubMed ID: 11426955
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neoadjuvant chemotherapy prior to pelvic exenteration in patients with recurrent cervical cancer: single institution experience.
    Landoni F; Zanagnolo V; Rosenberg PG; Lopes A; Radice D; Bocciolone L; Aletti G; Parma G; Colombo N; Maggioni A
    Gynecol Oncol; 2013 Jul; 130(1):69-74. PubMed ID: 23474343
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Analysis of prognostic factors in patients with cervical squamous cell carcinoma of stage Ib and IIa].
    Chen L; Lü WG; Xie X; Chen HZ; Yu H; Ni XH
    Zhonghua Fu Chan Ke Za Zhi; 2005 Apr; 40(4):239-42. PubMed ID: 15924669
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinicopathological features influencing pelvic lymph node metastasis and vaginal and parametrial involvement in patients with carcinoma of the cervix.
    Silva-Filho AL; Reis FM; Traiman P; Pedrosa MS; Miranda D; Triginelli SA
    Gynecol Obstet Invest; 2005; 59(2):92-6. PubMed ID: 15583463
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Analysis of the relationship between clinicopathological features and pelvic lymph node metastasis in patients with early stage squamous cell carcinoma of the uterine cervix].
    Tian QF; Wang XY; Lü WG; Ye F; Xie X
    Zhonghua Fu Chan Ke Za Zhi; 2008 Oct; 43(10):760-3. PubMed ID: 19087544
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preoperative concurrent radiation therapy and chemotherapy for bulky stage IB2, IIA, and IIB carcinoma of the uterine cervix with proximal parametrial invasion.
    Huguet F; Cojocariu OM; Levy P; Lefranc JP; Darai E; Jannet D; Ansquer Y; Lhuillier PE; Benifla JL; Seince N; Touboul E
    Int J Radiat Oncol Biol Phys; 2008 Dec; 72(5):1508-15. PubMed ID: 18676093
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lack of any impact of histopathology type on prognosis in patients with early-stage adenocarcinoma and squamous cell carcinoma of the uterine cervix.
    Teke F; Yoney A; Teke M; Inal A; Urakci Z; Eren B; Zincircioglu SB; Buyukpolat MY; Ozer A; Isikdogan A; Unsal M
    Asian Pac J Cancer Prev; 2014; 15(6):2815-9. PubMed ID: 24761906
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.